ResearcherUniversity of BernActive in the last 2 years
Aurel A. Perren
Matched on ORCID iD 0000-0002-6819-6092; OpenAlex author ID A5046167689, A5104911209. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 12
- RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2026.101010↗
- Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heteroge… Co-author DOI 10.1038/s41416-025-02959-w↗
- Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-24-0368↗
- Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-329371↗
- High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity. Last author DOI 10.1016/j.ejca.2022.03.033↗
- PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups. Last author DOI 10.1158/2326-6066.cir-21-0144↗
- Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imagin… Co-author DOI 10.1002/prca.201800046↗
- Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance. Co-author DOI 10.1158/1078-0432.ccr-17-3401↗
- PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. Co-author DOI 10.1016/j.ejca.2016.06.013↗
- Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal … Co-author DOI 10.1038/bjc.2015.177↗
- Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an inde… Co-author DOI 10.18632/oncotarget.2775↗
- Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic du… Last author DOI 10.1186/1479-5876-11-311↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Beat Gloor · 11 shared papers, 2013–2026 · strength 1.69
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Eva Karamitopoulou · 11 shared papers, 2013–2026 · strength 1.69
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Anna Silvia Wenning · 4 shared papers, 2022–2026 · strength 0.97
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Pauline Aeschbacher · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Animesh Acharjee · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Martin Wartenberg · 5 shared papers, 2015–2025 · strength 0.52
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Progno… DOI 10.1158/1078-0432.ccr-17-3401↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Alessandro Lugli · 5 shared papers, 2013–2025 · strength 0.49
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Paper Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-typ… DOI 10.18632/oncotarget.2775↗
- José A. Galván · 3 shared papers, 2015–2025 · strength 0.39
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Paper PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metas… DOI 10.1016/j.ejca.2016.06.013↗
- Andréas Andreou · 2 shared papers, 2021–2022 · strength 0.36
- Paper High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival … DOI 10.1016/j.ejca.2022.03.033↗
- Paper PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgr… DOI 10.1158/2326-6066.cir-21-0144↗
- Konstantin Bräutigam · 1 shared paper, 2026 · strength 0.33
- Erik Vassella · 2 shared papers, 2016–2018 · strength 0.13
- Paper Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Progno… DOI 10.1158/1078-0432.ccr-17-3401↗
- Paper PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metas… DOI 10.1016/j.ejca.2016.06.013↗
- Jörg Kriegsmann · 1 shared paper, 2019 · strength 0.10
- Rita Casadonte · 1 shared paper, 2019 · strength 0.10
- Thilo Welsch · 1 shared paper, 2019 · strength 0.10
- Christian P. Pilarsky · 1 shared paper, 2019 · strength 0.10
- Mathias Worni · 1 shared paper, 2018 · strength 0.08
- Agathi I. Kondi-Pafiti · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.